topotecan has been researched along with 1,2-distearoyllecithin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burke, TG; Gao, X | 1 |
Alnajim, J; Anantha, M; Bally, MB; Ramsay, E; Taggar, AS; Thomas, A; Webb, M | 1 |
Anderson, BD; Fugit, KD | 1 |
3 other study(ies) available for topotecan and 1,2-distearoyllecithin
Article | Year |
---|---|
Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine.
Topics: Antineoplastic Agents; Buffers; Camptothecin; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Humans; Hydrogen-Ion Concentration; Lactones; Liposomes; Phosphatidylcholines; Topotecan | 1994 |
Copper-topotecan complexation mediates drug accumulation into liposomes.
Topics: Buffers; Calcimycin; Cations, Divalent; Chemical Precipitation; Cholesterol; Copper; Cryoelectron Microscopy; Doxorubicin; Drug Compounding; Hydrogen-Ion Concentration; Lactones; Liposomes; Manganese Compounds; Molecular Structure; Nigericin; Phosphatidylcholines; Proton-Motive Force; Sulfates; Topotecan | 2006 |
The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.
Topics: Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Liposomes; Membranes, Artificial; Models, Biological; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Topoisomerase I Inhibitors; Topotecan | 2014 |